Study objectives: To characterize the prevalence of undiagnosed pulmon
ary hypertension in patients with limited and diffuse scleroderma. Des
ign: Prospective cross-sectional study. Setting: University-based outp
atient clinic. Patients: Thirty-four consecutive patients with limited
(n=29) or diffuse (n=5) scleroderma but without the clinical diagnosi
s of pulmonary hypertension, Measurements and results: All patients ha
d 12-lead ECGs and two-dimensional and Doppler echocardiograms. The pu
lmonary artery systolic pressure (PA(s)) as calculated as the sum of t
he Doppler transtricuspid pressure gradient and the right atrial press
ure as estimated by the caval respiratory index. Thirty-three patients
(97%) had adequate spectral signals of tricuspid regurgitation. Tile
velocity of tricuspid regurgitation ranged from 1.6 to 4.5 mis. The ca
lculated PA(s) ranged from 15 to 95 (mean+/-SD=30+/-14 mm Hg). Twelve
patients (35% of the total cohort) had pulmonary hypertension defined
as PA(s) of 30 mm Hg or greater. Conclusions: Undiagnosed elevation of
PA(s) is common in patients with scleroderma. Noninvasive assessment
of PA, can be performed accurately in most patients independent of cli
nical signs of pulmonary hypertension. If successful treatment strateg
ies are identified, it may be possible to identify patients early in t
he development of pulmonary hypertension and intervene before signific
ant end-organ damage occurs.